This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of DexCom Inc. slipped 9.1% to $70.72 on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 2.7% to 5,614.56 and Dow Jones Industrial Average falling 2.1% to 41,911.71.
This was the stock's sixth consecutive day of losses.
DexCom Inc. closed 50.2% short of its 52-week high of $142.00, which the company reached on March 26th.
The stock underperformed when compared to some of its competitors, as Abbott Laboratories rose 0.2% to $137.36, Insulet Corp. fell 5.9% to $237.06.
Trading volume totaled 8.3 million, compared to the 50-day average of 3.5 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
March 10, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。